Clinical Trial Update: A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of TQH3906 for systemic lupus erythematosus. The study is not yet recruiting and is sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• TQH3906

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: NOT_YET_RECRUITING